Loading…
About This Symposium
The INEDSYS Virtual Advances in Liver Disease & Transplant Symposium 2026 is a multidisciplinary program providing healthcare professionals with updated insights in hepatology and liver transplantation. This virtual symposium will feature expert-led discussions on emerging therapies, MASLD/MASH, alcohol-associated liver disease, innovations in liver transplantation, endohepatology, hepatocellular carcinoma, nutrition and frailty, and the growing role of artificial intelligence and digital health in liver care. The program aims to foster collaboration, enhance clinical knowledge, and drive innovation in the management of liver disease and transplant medicine.
Key Learning Objectives
- 01Evaluate emerging therapies for MASLD/MASH and alcohol-associated liver disease.
- 02Apply current strategies for HCC screening, downstaging, and immunotherapy in transplantation
- 03Assess the role of AI, remote monitoring, and endohepatology in liver care
- 04Integrate nutrition and frailty assessment into chronic liver disease management
- 05Describe genetic diagnostics and new therapies for rare liver diseases, including PBC
Speakers
Experts across hepatology and GI medicine
Dr. Wojciech G. Polak
MD, PhD, FEBS (HPB & Transplant Surgery)
MK
Dr. Mohammed el Kassas
MD
Dr. Gene Im
TB
Dr. TBD
MD
Dr. Kym Watt
Prof. Neil Mehta
MD
Full agenda, slides, and recordings
Sign in to see the complete program, the session-by-session agenda, the speakers' slides, and the recording after the event. It is free for clinicians.
Sign in to register
